Publisher: Icon Group International, Inc.
Category: Diseases & Conditions

Diseases & Conditions market research reports by Icon Group International, Inc.

(630 reports matching your criteria)
    • The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)

      The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2025-2030 World Outlook for Colorectal Cancers

      The 2025-2030 World Outlook for Colorectal Cancers This study covers the world outlook for colorectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Postoperative Pain Therapeutics

      The 2025-2030 World Outlook for Postoperative Pain Therapeutics This study covers the world outlook for postoperative pain therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Neurodegenerative Diseases

      The 2025-2030 World Outlook for Neurodegenerative Diseases This study covers the world outlook for neurodegenerative diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Systemic Hypertension Drugs

      The 2025-2030 World Outlook for Systemic Hypertension Drugs This study covers the world outlook for systemic hypertension drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Syphilis Immunoassay Diagnostics

      The 2025-2030 World Outlook for Syphilis Immunoassay Diagnostics This study covers the world outlook for syphilis immunoassay diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Allergic Rhinitis

      The 2025-2030 World Outlook for Allergic Rhinitis This study covers the world outlook for allergic rhinitis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Diabetic Macular Edema Treatments

      The 2025-2030 World Outlook for Diabetic Macular Edema Treatments This study covers the world outlook for diabetic macular Edema treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Food Allergy Diagnostics and Therapeutics

      The 2025-2030 World Outlook for Food Allergy Diagnostics and Therapeutics This study covers the world outlook for food allergy diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs

      The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs This study covers the world outlook for targeted therapy liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Non-Melanoma Skin Cancers

      The 2025-2030 World Outlook for Non-Melanoma Skin Cancers This study covers the world outlook for non-melanoma skin cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics

      The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics This study covers the world outlook for noninvasive cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Next Generation Diabetes Therapy and Drug Deliveries

      The 2025-2030 World Outlook for Next Generation Diabetes Therapy and Drug Deliveries This study covers the world outlook for next generation diabetes therapy and drug deliveries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More

    • The 2025-2030 World Outlook for Lymphoma Treatments

      The 2025-2030 World Outlook for Lymphoma Treatments This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Allergy Medicines

      The 2025-2030 World Outlook for Allergy Medicines This study covers the world outlook for allergy medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Malignant Melanoma Treatments

      The 2025-2030 World Outlook for Malignant Melanoma Treatments This study covers the world outlook for malignant melanoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments

      The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments This study covers the world outlook for bile duct cancer (cholangiocarcinoma) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More

    • The 2025-2030 World Outlook for Disposable Blood Pressure Cuffs

      The 2025-2030 World Outlook for Disposable Blood Pressure Cuffs This study covers the world outlook for disposable blood pressure cuffs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Non-Opioid Pain Patches

      The 2025-2030 World Outlook for Non-Opioid Pain Patches This study covers the world outlook for non-opioid pain patches across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs

      The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis

      The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis This study covers the world outlook for beta interferon therapeutics for multiple sclerosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ear ... Read More

    • The 2025-2030 World Outlook for Cancer Cachexia

      The 2025-2030 World Outlook for Cancer Cachexia This study covers the world outlook for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Pain Management

      The 2025-2030 World Outlook for Pain Management This study covers the world outlook for pain management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Migraine Treatments

      The 2025-2030 World Outlook for Migraine Treatments This study covers the world outlook for migraine treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Huntington's Disease Therapeutics

      The 2025-2030 World Outlook for Huntington's Disease Therapeutics This study covers the world outlook for Huntington's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

6 7 8 9 10 11 12 13 14 15

Cookie Settings